Legal Opinion
Frater v. Hemispherx Biopharma, Inc.
District Court, E.D. Pennsylvania
Decided January 24, 2014No. 2:12-cv-07152-WYPublishedCited by 14 opinions
1Opinion of the Court
MEMORANDUM
YOHN, District Judge.
This is a consolidated class action in which plaintiffs are shareholders or former shareholders of Hemispherx Biopharma, Inc. (“Hemispherx”). Plaintiffs claim securities fraud under § 10(b) of the Securities Exchange Act of 1934 (“Exchange Act”) and Rule 10b-5 thereunder against Hemispherx; its President and Chairman of the Board Dr. William A. Carter; its Medical Director and Chief Medical Officer David Strayer; and its Senior Advisor Wayne Pambianchi. They further claim Hemispherx and Carter violated § 20(a) of the Exchange Act. The plaintiffs purport to…
2Cases cited10 opinions
- Ashcroft v. IqbalSupreme Court of the United States · 2009
- Phillips v. County of AlleghenyCourt of Appeals for the Third Circuit · 2008
- Tellabs, Inc. v. Makor Issues & Rights, Ltd.Supreme Court of the United States · 2007
- In Re Burlington Coat Factory Securities Litigation. P. Gregory Buchanan, Jacob Turner and Ronald AbramoffCourt of Appeals for the Third Circuit · 1997
- Santiago v. Warminster TownshipCourt of Appeals for the Third Circuit · 2010
5 more not listed; retrieve them via the Exa API.
3Cited by14 opinions
- In re Egalet Corp.District Court, E.D. Pennsylvania · 2018
- In re Urban Outfitters, Inc. Securities LitigationDistrict Court, E.D. Pennsylvania · 2015
- Gregory v. Pronai Therapeutics Inc.District Court, S.D. Illinois · 2018
- Corban v. Sarepta Therapeutics, Inc.Court of Appeals for the First Circuit · 2017
- In re Viropharma Inc. Securities LitigationDistrict Court, E.D. Pennsylvania · 2014
9 more not listed; retrieve them via the Exa API.